Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis
AustriaStudy on Tildrakizumab for Patients with Active Psoriatic Arthritis Who Have Not Used Anti-TNF Therapy
CzechiaStudy on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis
BulgariaStudy on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis
BelgiumStudy on the Effects of Atuliflapon in Adults with Moderate to Severe Uncontrolled Asthma
BulgariaStudy on the Effectiveness and Safety of Barzolvolimab in Adults with Active Eosinophilic Esophagitis
GermanyStudy of anifrolumab effectiveness compared to placebo in adults aged 18-70 with systemic sclerosis
AustriaSafety Study of Efgartigimod in Adults with Primary Sjögren's Syndrome
BelgiumStudy on Tezepelumab for Reducing Steroid Use in Adults with Steroid-Dependent Asthma
CzechiaStudy on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Systemic Lupus Erythematosus
HungaryStudy Comparing CT-P53 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis
BulgariaStudy on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma
BulgariaThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
